Education
About Us
Working with TipRanks
Follow Us
Emergent Biosolutions (EBS)
NYSE:EBS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.01B | $ 1.05B | $ 1.12B | $ 1.79B | $ 1.56B |
| Gross Profit | $ 1.01B | $ 343.90M | $ 427.20M | $ 1.04B | $ 1.03B |
| Operating Income | $ -108.70M | $ -726.40M | $ -166.00M | $ 352.60M | $ 433.80M |
| EBITDA | $ 36.90M | $ -505.30M | $ -32.90M | $ 458.20M | $ 549.00M |
| Net Income | $ -190.60M | $ -760.50M | $ -223.80M | $ 219.50M | $ 305.80M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 99.50M | $ 111.70M | $ 642.60M | $ 576.10M | $ 621.30M |
| Total Assets | $ 1.39B | $ 1.82B | $ 3.17B | $ 2.96B | $ 2.88B |
| Total Debt | $ 663.70M | $ 860.20M | $ 1.41B | $ 841.00M | $ 874.80M |
| Net Debt | $ 564.20M | $ 748.50M | $ 763.20M | $ 264.90M | $ 253.50M |
| Total Liabilities | $ 906.90M | $ 1.17B | $ 1.78B | $ 1.34B | $ 1.44B |
| Stockholders' Equity | $ 482.80M | $ 649.30M | $ 1.38B | $ 1.62B | $ 1.45B |
| Cash Flow | |||||
| Free Cash Flow | $ 35.80M | $ -257.90M | $ -149.90M | $ 96.10M | $ 395.00M |
| Operating Cash Flow | $ 58.70M | $ -206.30M | $ -34.10M | $ 321.10M | $ 536.00M |
| Investing Cash Flow | $ 125.20M | $ 212.30M | $ -381.30M | $ -225.00M | $ -151.00M |
| Financing Cash Flow | $ -190.00M | $ -535.70M | $ 481.20M | $ -141.00M | $ 69.50M |